Carlo Clerici

6α-Ethyl-Chenodeoxycholic Acid (6-ECDCA), a Potent and Selective FXR Agonist Endowed with Anticholestatic Activity

Roberto Pellicciari, Stefano Fiorucci, Emidio Camaioni et al. · Journal of Medicinal Chemistry · 2002 · 722 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Selective Fxr Agonist +14

S-Equol, a potent ligand for estrogen receptor β, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora1–4,

Kenneth D.R. Setchell, Carlo Clerici, Edwin D. Lephart et al. · American Journal of Clinical Nutrition · 2005 · 455 citations

Soy Isoflavone Metabolite, Estrogen Receptor β, Biochemistry +8

Protective Effects of 6-Ethyl Chenodeoxycholic Acid, a Farnesoid X Receptor Ligand, in Estrogen-Induced Cholestasis

Stefano Fiorucci, Carlo Clerici, Elisabetta Antonelli et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 193 citations

Bile Acid Derivatives as Ligands of the Farnesoid X Receptor. Synthesis, Evaluation, and Structure−Activity Relationship of a Series of Body and Side Chain Modified Analogues of Chenodeoxycholic Acid

Roberto Pellicciari, Gabriele Costantino, Emidio Camaioni et al. · Journal of Medicinal Chemistry · 2004 · 188 citations · Full text

Deficiency of Thrombin Activatable Fibrinolysis Inhibitor in Cirrhosis Is Associated With Increased Plasma Fibrinolysis

Mario Colucci, Bianca M. Binetti, Maria G. Branca et al. · Hepatology · 2003 · 144 citations

Tafi Deficiency, Vitro Plasma Hyperfibrinolysis, Vitro Fibrinolysis +21